Evidence-Based Practice Proposal

These are some of the recommendations that will assist clinicians Understanding the current practice patterns in primary and secondary prevention in different settings is an important initial step in scaling up prevention activities at state level. These approaches need to be developed to narrow the implementation gap between evidence-based guidelines and the lifestyle, risk factor and therapeutic management of patients with CVD. In addition, qualitative research will be important in examining the motivation of patients to adhere to treatment, the motivation of practitioners to adopt evidence-based practice, and the barriers to making changes in existing systems. Further initiatives that are aimed at scaling up prevention should monitor

At a minimum, these systems should measure cardiovascular risk factors and social determinants in randomly selected populations and monitor cardiovascular risk changes over time. These systems need to be institutionalized within the national surveillance system for sustainability.
An underappreciated problem, amenable to research, is the way in which a highly effective intervention can be rendered near useless through a chain of inefficiency in the health care delivery system. Research to enhance each step in the chain would be highly beneficial in ensuring that health care spending generates the expected level of return on the investment. This could be applied as a useful framework to develop a research portfolio for scaling up primary and secondary prevention.
It is important to establish knowledge and beliefs about CVD and about attitudes to prevention among the general population, patients and health professionals. If current beliefs suggest that the diseases are not preventable, or knowledge about causes is incorrect, this may impede progress towards prevention. Patient and physician barriers to guideline implementation need to be identified and ways found to overcome them through